Cargando…
PI3K‐α/mTOR/BRD4 inhibitor alone or in combination with other anti‐virals blocks replication of SARS‐CoV‐2 and its variants of concern including Delta and Omicron
Autores principales: | Acharya, Arpan, Pathania, Anup S., Pandey, Kabita, Thurman, Michellie, Vann, Kendra R., Kutateladze, Tatiana G., Challagundala, Kishore B., Durden, Donald L., Byrareddy, Siddappa N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989379/ https://www.ncbi.nlm.nih.gov/pubmed/35390226 http://dx.doi.org/10.1002/ctm2.806 |
Ejemplares similares
-
Binding of the SARS-CoV-2 envelope E protein to human BRD4 is essential for infection
por: Vann, Kendra R., et al.
Publicado: (2022) -
Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
por: Acharya, Arpan, et al.
Publicado: (2021) -
Biomarkers of Activation and Inflammation to Track Disparity in Chronological and Physiological Age of People Living With HIV on Combination Antiretroviral Therapy
por: Thurman, Michellie, et al.
Publicado: (2020) -
Mental Health Issues During and After COVID-19 Vaccine Era
por: Pandey, Kabita, et al.
Publicado: (2021) -
Characterization of multiple interactions between the envelope E protein of SARS-CoV-2 and human BRD4
por: Zandian, Mohamad, et al.
Publicado: (2022)